-
公开(公告)号:US20210371542A1
公开(公告)日:2021-12-02
申请号:US16762459
申请日:2018-11-07
发明人: Mitchell Ho , Nan Li , Dan Li
IPC分类号: C07K16/30 , C07K14/715 , C07K14/71 , C07K14/705 , C07K14/725 , A61K35/17 , A61P35/00
摘要: Nucleic acid constructs encoding a chimeric antigen receptor (CAR) and a truncated human epidermal growth factor receptor (huEGFRt) are described. The encoded CARs include a tumor antigen-specific monoclonal antibody, such as a glypican-3 (GPC3)-specific, a GPC2-specific or a mesothelin-specific monoclonal antibody, fused to a CD8α hinge region, a CD8α transmembrane region, a 4-1BB co-stimulatory domain and a CD3ζ signaling domain. Isolated host cells, such as isolated T cells that co-express the disclosed CARs and huEGFRt are also described. T cells transduced with the disclosed CAR constructs can be used for cancer immunotherapy.
-
公开(公告)号:US12122843B2
公开(公告)日:2024-10-22
申请号:US17422609
申请日:2020-01-15
发明人: Mitchell Ho , Nan Li , Jiajia Pan
CPC分类号: C07K16/303 , A61K47/6829 , A61K47/6929 , A61P35/04 , C07K14/4725 , A61K2039/505
摘要: Monoclonal antibodies that specifically bind glypican-1 (GPC1) are described. Chimeric antigen receptor (CAR) T cells, immunotoxins and other antibody conjugates based on the GPC1-specific antibodies are also described. The disclosed CAR T cells, immunotoxins, GPC1-specific antibodies and conjugates thereof can be used, for example, in the diagnosis or treatment of GPC1-positive pancreatic cancer and other cancers.
-
公开(公告)号:US20230406953A1
公开(公告)日:2023-12-21
申请号:US18359071
申请日:2023-07-26
发明人: Mitchell Ho , Nan Li , Dan Li
IPC分类号: C07K16/30 , A61P35/00 , A61K35/17 , C07K14/725 , C07K14/705 , C07K14/71 , C07K14/715
CPC分类号: C07K16/303 , A61P35/00 , A61K35/17 , C07K14/7051 , C07K14/70517 , C07K14/70521 , C07K14/70578 , C07K14/71 , C07K14/7153 , A61K2039/505
摘要: Nucleic acid constructs encoding a chimeric antigen receptor (CAR) and a truncated human epidermal growth factor receptor (huEGFRt) are described. The encoded CARs include a tumor antigen-specific monoclonal antibody, such as a glypican-3 (GPC3)-specific, a GPC2-specific or a mesothelin-specific monoclonal antibody, fused to a CD8α hinge region, a CD8α transmembrane region, a 4-1BB co-stimulatory domain and a CD3ζ signaling domain. Isolated host cells, such as isolated T cells that co-express the disclosed CARs and huEGFRt are also described. T cells transduced with the disclosed CAR constructs can be used for cancer immunotherapy.
-
公开(公告)号:US11802163B2
公开(公告)日:2023-10-31
申请号:US16762459
申请日:2018-11-07
发明人: Mitchell Ho , Nan Li , Dan Li
IPC分类号: C07K16/30 , A61P35/00 , A61K35/17 , C07K14/725 , C07K14/705 , C07K14/71 , C07K14/715 , A61K39/00
CPC分类号: C07K16/303 , A61K35/17 , A61P35/00 , C07K14/7051 , C07K14/70517 , C07K14/70521 , C07K14/70578 , C07K14/71 , C07K14/7153 , A61K2039/505 , C07K2317/569 , C07K2317/622 , C07K2319/02 , C07K2319/03
摘要: Nucleic acid constructs encoding a chimeric antigen receptor (CAR) and a truncated human epidermal growth factor receptor (huEGFRt) are described. The encoded CARs include a tumor antigen-specific monoclonal antibody, such as a glypican-3 (GPC3)-specific, a GPC2-specific or a mesothelin-specific monoclonal antibody, fused to a CD8α hinge region, a CD8α transmembrane region, a 4-1BB co-stimulatory domain and a CD3ζ signaling domain. Isolated host cells, such as isolated T cells that co-express the disclosed CARs and huEGFRt are also described. T cells transduced with the disclosed CAR constructs can be used for cancer immunotherapy.
-
5.
公开(公告)号:US20230340146A1
公开(公告)日:2023-10-26
申请号:US18020191
申请日:2021-08-10
发明人: Mitchell Ho , Nan Li , Jessica Diana Hong
IPC分类号: C07K14/725 , C12N15/86 , C07K16/30 , A61P35/00
CPC分类号: C07K16/303 , A61P35/00 , C07K14/7051 , C12N15/86 , C07K2317/53 , C07K2317/565 , C07K2317/569 , C07K2317/622 , C07K2319/02 , C07K2319/03
摘要: Optimized chimeric antigen receptors (CARs) targeting glypican-1 (GPC1) that include a 12-amino acid hinge region from IgG4 are described. The optimized CARs include a transmembrane domain from either CD8 or CD28. Immune cells, such as T cells or natural killer cells, expressing the optimized CARs can be used to treat GPC1-positive solid tumors.
-
公开(公告)号:US20240301084A1
公开(公告)日:2024-09-12
申请号:US18661979
申请日:2024-05-13
发明人: Mitchell Ho , Nan Li , Bryan D. Fleming
IPC分类号: C07K16/30 , A61K39/00 , A61K47/68 , A61P35/00 , C07K14/725 , C12N15/86 , G01N33/574
CPC分类号: C07K16/30 , A61K47/6829 , A61P35/00 , C07K14/7051 , C12N15/86 , G01N33/5748 , A61K2039/505
摘要: Monoclonal antibodies that bind glypican-2 (GPC2) with high affinity are described. Immunotoxins and chimeric antigen receptors (CARs) that include the disclosed antibodies or antigen-binding fragments thereof are further described. In some instances, the antibody or antigen-binding fragment is humanized. The disclosed GPC2-specific antibodies and conjugates can be used, for example, for the diagnosis or treatment of GPC2-positive cancers, including neuroblastoma, medulloblastoma and retinoblastoma.
-
公开(公告)号:US11066479B2
公开(公告)日:2021-07-20
申请号:US16322712
申请日:2017-07-20
发明人: Mitchell Ho , Nan Li , Dimiter S. Dimitrov
摘要: A panel of human variable heavy (VH) single domain monoclonal antibodies specific for cell-surface glypican-2 (GPC2) are described. Methods for the diagnosis and treatment and GPC2-positive cancer are also described. Recombinant immunotoxins comprised of a GPC2-specific VH domain antibody and a clinically used form of Pseudomonas exotoxin A (PE38) were generated and shown to inhibit GPC2-positive neuroblastoma tumor cell growth and inhibit neuroblastoma xenograft growth in nude mice, without significant toxicity. Chimeric antigen receptors comprising a GPC2-specific VH single domain antibody are also described. T cells expressing the GPC2-specific CARs potently killed GPC2-positive neuroblastoma cells in a dose-dependent manner.
-
公开(公告)号:US12012463B2
公开(公告)日:2024-06-18
申请号:US17266419
申请日:2019-08-06
发明人: Mitchell Ho , Nan Li , Bryan D. Fleming
IPC分类号: C07K16/30 , A61K47/68 , A61P35/00 , C07K14/725 , C12N15/86 , G01N33/574 , A61K39/00
CPC分类号: C07K16/30 , A61K47/6829 , A61P35/00 , C07K14/7051 , C12N15/86 , G01N33/5748 , A61K2039/505
摘要: Monoclonal antibodies that bind glypican-2 (GPC2) with high affinity are described. Immunotoxins and chimeric antigen receptors (CARs) that include the disclosed antibodies or antigen-binding fragments thereof are further described. In some instances, the antibody or antigen-binding fragment is humanized. The disclosed GPC2-specific antibodies and conjugates can be used, for example, for the diagnosis or treatment of GPC2-positive cancers, including neuroblastoma, medulloblastoma and retinoblastoma.
-
公开(公告)号:US20220064324A1
公开(公告)日:2022-03-03
申请号:US17421334
申请日:2020-01-02
发明人: Mitchell Ho , Ira H. Pastan , Jessica D. Hong , Nan Li
IPC分类号: C07K16/30 , C07K14/705 , C07K14/725 , A61K47/68 , C07K16/28 , A61K47/69 , C07K14/715 , C07K14/71 , A61P35/00
摘要: Camel single-domain monoclonal antibodies that specifically bind human and mouse mesothelin are described. Chimeric antigen receptor (CAR) T cells and antibody conjugates based on the mesothelin-specific antibodies are also described. The disclosed CAR T cells, mesothelin-specific antibodies and conjugates thereof can be used, for example, in the diagnosis or treatment of mesothelin-positive cancers.
-
公开(公告)号:US20210292428A1
公开(公告)日:2021-09-23
申请号:US17266419
申请日:2019-08-06
发明人: Mitchell Ho , Nan Li , Bryan D. Fleming
IPC分类号: C07K16/30 , C07K14/725 , A61K47/68 , G01N33/574 , C12N15/86 , A61P35/00
摘要: Monoclonal antibodies that bind glypican-2 (GPC2) with high affinity are described. Immunotoxins and chimeric antigen receptors (CARs) that include the disclosed antibodies or antigen-binding fragments thereof are further described. In some instances, the antibody or antigen-binding fragment is humanized. The disclosed GPC2-specific antibodies and conjugates can be used, for example, for the diagnosis or treatment of GPC2-positive cancers, including neuroblastoma, medulloblastoma and retinoblastoma.
-
-
-
-
-
-
-
-
-